OakChart

MindWalk Holdings Corp

HYFTHealthcare·Biotechnology·USA·Nano·NASD·Nov 11 • 3:59 PM ET

1.030.00 (0.00%)
2026-11-12 05:25 CET
Market cap
49.00 USD m
Revenue, TTM
11.72 USD m
Net income, TTM
-12.31 USD m
Free cash flow, TTM
-9.06 USD m
EPS diluted, TTM
-0.26
P/E
-
Compare

Price

HYFT against its 20, 50 and 200-day averages
2050200earnings
1.001.251.501.752.001.3M2.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HYFTclose 1.0320-day 1.1650-day 1.29200-day 1.351.0352w low

65.6% under the 52-week high of 2.99 on 12 Jan 2026. 52-week low 0.97 on 10 Nov 2026. Last 15 sessions, 34.2% high to low

Volume 0.34× normal · the line is the 50-bar volume average

Profile

HYFT
52-week range, 3% of the way up
0.972.99

MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. It operates through the following geographical segments: United States of America, Europe, Canada, Australia, and Other. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Austin, TX.

Employees77
IPONov 06, 2003
Beta0.79
ATR, 14d0.10
Rel volume0.34
Short float2.45%
Insider own9.45%
Inst own9.17%

Snapshot

6 groups

Valuation

Index-
Market Cap49.00M
Enterprise Value46.05M
Income-12.31M
Sales11.72M
Book/sh0.10
Cash/sh0.11
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees77
IPONov 06, 2003

Ratios

P/E-
Forward P/E-
PEG-
P/S4.18
P/B9.82
P/C9.02
P/FCF-
EV/EBITDA-
EV/Sales3.93
Quick Ratio1.75
Current Ratio1.84
Debt/Eq0.50
LT Debt/Eq0.43
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.26
EPS next Y-0.25
EPS next Q-0.06
EPS this Y-24.73%
EPS next Y14.00%
EPS next 5Y3.72%
EPS past 3/5Y35.25% 8.52%
Sales past 3/5Y-10.15% -3.79%
EPS Y/Y TTM56.50%
Sales Y/Y TTM-26.89%
EPS Q/Q-99.36%
Sales Q/Q19.36%
EarningsSep 14 AMC
EPS/Sales Surpr.-71.88% -14.12%

Ownership

Insider Own9.45%
Insider Trans0.00%
Inst Own9.17%
Inst Trans-0.55%
ROA-58.96%
ROE-123.73%
ROIC-174.26%
Gross Margin60.79%
Oper. Margin-104.08%
Profit Margin-105.08%
SMA20-11.25%
SMA50-19.85%
SMA200-23.97%
Trades-

Technical

Shs Outstand46.99M
Shs Float43.08M
Short Float2.45%
Short Ratio4.47
Short Interest1.06M
52W High2.99 -65.55%
52W Low0.97 6.33%
Volatility7.54% 8.49%
ATR (14)0.10
RSI (14)35.24
Beta0.79
Rel Volume0.34
Avg Volume236.43K
Volume80,309

Performance

Perf Week-0.96%
Perf Month-30.41%
Perf Quarter-25.90%
Perf Half Y-18.25%
Perf YTD-43.41%
Perf Year-42.46%
Perf 3Y-33.97%
Perf 5Y-82.69%
Perf 10Y5182.05%
Recom1.00
Target Price4.32
Prev Close1.03
Price1.03
Change %0.00%

Analyst ratings

latest 2 of 2
DateActionAnalystRating changeTargetImplied
Dec 02, 2022InitiatedHH.C. WainwrightBuy$9+773.8%
Oct 25, 2021InitiatedTThe Benchmark CompanyBuy$12+1,065.0%

Peers

Mkt cap
TickerCompanyMkt cap
ABCLAbCellera Biologics Inc3.90B
ABSIAbsci Corp1.74B
ADAGAdagene Inc ADR143.01M
RXRXRecursion Pharmaceuticals Inc2.24B
EVAXEvaxion A/S ADR24.27M
TWSTTwist Bioscience Corp8.07B
DNAGinkgo Bioworks Holdings Inc679.14M
LTRNLantern Pharma Inc7.19M
SDGRSchrodinger Inc2.37B
CERTCertara Inc1.79B

Held by

AUM
TickerCompanyAUM
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 196
  • MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows (Business Wire) -5.45%
  • MindWalk Holdings Corp. Announces Leadership Update (Business Wire) -5.51%
  • MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours (Business Wire)
  • MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies (Business Wire) -7.43%
  • MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function (Business Wire)
  • AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment (PR Newswire)
  • MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director (Business Wire)
  • MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine (Business Wire) +8.09%
  • MindWalk Holdings Corp (HYFT) (Q1 2027) Earnings Call Highlights: Revenue Climbs 21% as ReefIQ ... (GuruFocus.com) -13.16%
  • MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027 (Business Wire)
  • AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033 (PR Newswire)
  • MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion (Business Wire)
  • MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference (Business Wire)
  • MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026 (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-09-14-0.094-0.0540.0002.763.213
2025Q42026-07-22-0.057-0.051-0.0602.923.203
2025Q32026-03-12-0.059-0.040-0.0613.063.372
2025Q22025-12-15-0.051-0.036-0.0503.003.152
2025Q12025-09-15-0.065-0.044-0.0475.494.302
2024Q42025-07-29-0.036-0.037-0.0335.085.782
2024Q32025-03-28-0.461-0.056-0.4614.304.891
2024Q22024-12-10-0.064-0.068-0.0664.324.602
2024Q12024-09-16-0.111-0.080-0.1083.904.912
2023Q42024-07-29-0.524-0.084-0.4944.674.792
2023Q32024-03-14-0.082-0.074-0.0844.604.492
2023Q22023-12-14-0.074-0.096-0.0774.574.312
2023Q12023-09-14-0.103-0.154-0.1074.204.032
2022Q42023-07-07-0.151-0.125-0.1514.204.202
2022Q32023-03-16-0.140-0.230-0.1403.785.432
2022Q22022-12-15-0.221-0.190-0.2223.835.262

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.258--0.27210.39-
2020FY-0.358--0.34014.23-
2021FY-0.663-0.638-0.67615.1414.86
2022FY-0.787-0.765-0.80315.4915.24
2023FY-0.774-0.349-0.75417.7318.04
2024FY-0.663-0.461-0.65017.8518.60
2025FY-0.234-0.216-11.0411.50
2026FY--0.289--12.51
2027FY--0.248--15.18
2028FY--0.207--19.47
2029FY--0.135--24.32
2030FY--0.050--30.04

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q2S2026-09-223033.062.853.18
2026Q2S2026-09-153023.252.883.70
2026Q2S2026-09-143013.613.243.89
2026Q2S2026-07-233013.563.193.83
2026Q2S2026-06-302003.573.523.62
2026Q2S2026-05-262003.663.623.69
2026Q2S2026-04-142013.663.633.70
2026Q2S2026-03-121013.753.753.75
2026Q2S2026-02-281004.784.784.78
2026Q2S2026-01-091014.714.714.71
2026Q2S2025-12-151014.724.724.72
2026Q2S2025-11-111005.495.495.49
2026Q2S2025-11-101005.495.495.49
2026Q2S2025-11-091005.495.495.49

Estimate history

EPS, annual-0.43-0.461-0.272-0.34-0.676-0.803-0.754-0.65-0.218-0.2642
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.108-0.066-0.461-0.033-0.047-0.05-0.061-0.06-0.093
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Sales, annual4.2578.29610.5213.67715.43315.54518.1577.62611.27411.72
Period201720182019202020212022202320242025TTM
Sales, quarterly3.8434.4854.3314.912.32.9722.9973.0022.746
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Shares, annual11.09513.58813.98419.16924.47725.0526.94546.15446.71246.99
Period201720182019202020212022202320242025MRQ
Shares, quarterly27.30230.28845.76546.15446.15446.15746.71246.71246.99
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue11.7211.277.6318.1615.5515.4313.6810.528.30
Cost of Goods Sold Incl. D&A4.594.654.6111.4310.178.2813.5410.939.70
Gross Profit7.126.633.016.735.387.150.14-0.41-1.40
Selling, General and Administrative Excl. Other19.3217.4514.3017.1626.8620.505.422.653.32
Research and Development3.823.573.022.999.246.111.510.330.37
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-12.20-10.82-11.28-10.44-21.48-13.35-5.28-3.06-4.73
Interest Expense--0.010.010.020.070.490.530.64
Unusual Expense0.000.0015.2011.130.000.000.990.630.53
Net Income Before Taxes-12.48-11.27-27.01-21.26-20.88-12.63-4.58-3.96-5.78
Income Taxes-0.15-0.33-3.22-1.92-0.900.691.03-0.260.00
Consolidated Net Income-12.33-10.94-23.79-19.34-19.98-13.32-5.60-3.70-5.78
Net Income From Continuing Operations-12.33-10.94-23.79-19.34-19.98-13.32-5.60-3.70-5.78
Net Income-12.31-10.11-21.70-19.34-19.98-13.32-5.60-3.70-5.78
EPS (Recurring)-0.26-0.22-0.33-0.45-0.80-0.68-0.30-0.24-0.43
EPS (Basic, Before Extraordinaries)-0.26-0.22-0.65-0.75-0.80-0.68-0.34-0.27-0.46
EPS (Diluted)-0.26-0.22-0.65-0.75-0.80-0.68-0.34-0.27-0.46
EBITDA-11.53-9.66-7.61-6.19-16.45-10.34-2.45-0.51-3.01
Non-Operating Income (Expense)-0.28-0.45-0.510.330.620.792.180.260.11
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.040.680.230.841.242.091.540.410.62
Price To Sales Ratio5.154.901.921.814.127.0911.763.594.50
Gross Margin60.7958.8039.5437.0534.5946.321.03-3.92-16.92
Operating Margin-104.08-96.01-147.98-57.48-138.16-86.49-38.63-29.13-56.99
Net Margin-105.08-89.66-284.53-106.51-128.53-86.29-40.98-35.19-69.72
Shares Outstanding46.9946.7146.1526.9425.0524.4819.1713.9813.59
Market Capitalization49.0049.0010.9231.9264.08108.20186.2138.8140.42

Income statement, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q2
Total Revenue2.753.003.002.972.304.914.334.48
Cost of Goods Sold Incl. D&A1.141.181.221.051.191.852.452.42
Gross Profit1.611.821.781.921.113.061.882.07
Selling, General and Administrative Excl. Other6.004.984.423.924.144.104.204.15
Research and Development0.921.150.880.880.760.770.740.85
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-4.39-3.16-2.65-2.00-3.03-1.04-2.32-2.08
Interest Expense-----0.000.000.00
Unusual Expense0.000.000.000.000.000.0014.920.00
Net Income Before Taxes-4.24-3.09-2.85-2.30-3.04-1.34-17.28-2.24
Income Taxes0.11-0.27-0.010.02-0.070.18-2.12-0.37
Consolidated Net Income-4.36-2.82-2.83-2.32-2.97-1.52-15.15-1.87
Net Income From Continuing Operations-4.36-2.82-2.83-2.32-2.97-1.52-15.15-1.87
Net Income-4.36-2.82-2.83-2.30-2.15-1.52-15.15-1.87
EPS (Recurring)-0.09-0.06-0.06-0.05-0.05-0.03-0.14-0.07
EPS (Basic, Before Extraordinaries)-0.09-0.06-0.06-0.05-0.05-0.03-0.46-0.07
EPS (Diluted)-0.09-0.06-0.06-0.05-0.05-0.03-0.46-0.07
EBITDA-4.20-2.98-2.49-1.85-2.34-0.39-1.33-1.04
Non-Operating Income (Expense)0.140.07-0.20-0.30-0.01-0.30-0.04-0.16
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.390.550.030.080.030.030.040.08
Price To Sales Ratio5.154.935.725.954.781.150.880.76
Gross Margin58.5860.6359.2664.5548.3162.3743.4446.11
Operating Margin-159.86-105.20-88.36-67.29-131.57-21.11-53.47-46.38
Net Margin-158.71-93.92-94.52-77.47-93.61-30.96-349.88-41.68
Shares Outstanding46.9946.7146.7146.1646.1546.1545.7730.29
Market Capitalization49.0055.5975.6486.3176.6210.9211.6011.89

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments8.347.722.526.1023.4533.941.884.071.41
Short Term Receivables2.633.483.263.262.673.352.701.451.73
Inventories0.361.521.561.521.260.980.590.590.32
Other Current Assets0.590.861.021.501.941.440.380.250.27
Total Current Assets11.9213.588.3612.3829.3239.725.546.363.73
Net Property, Plant & Equipment2.9911.7712.507.913.073.312.281.221.23
Total Investments and Advances0.090.090.060.150.180.150.150.120.07
Intangible Assets0.006.7322.7436.9440.7111.2511.6613.466.97
Deferred Tax Assets0.700.00-------
Other Assets0.000.000.000.000.000.000.000.007.17
Total Assets15.7032.1743.6657.3773.2754.4319.6321.1619.17
Short Term Debt Incl. Current Port. of LT Debt0.341.341.140.821.800.802.072.100.15
Accounts Payable3.073.822.961.833.421.480.971.191.59
Income Tax Payable0.060.340.400.000.330.380.000.02-
Other Current Liabilities0.791.021.411.711.732.282.672.051.61
Total Current Liabilities4.256.525.914.367.274.945.715.363.34
Long Term Debt2.258.368.824.540.372.011.180.072.83
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.560.182.965.656.341.211.151.530.69
Other Liabilities0.000.000.000.200.390.000.730.772.40
Total Liabilities7.0715.0717.6914.7514.378.168.777.739.26
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity8.6317.1025.9742.6258.9146.2710.8613.439.91
Total Shareholders Equity8.6317.1025.9742.6258.9146.2710.8613.439.91
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity8.6317.1025.9742.6258.9146.2710.8613.439.91
Total Liabilities & Stockholders Equity15.7032.1743.6657.3773.2754.4319.6321.1619.17
Book Value Per Share0.180.370.961.702.412.410.780.990.89
Tangible Book Value Per Share0.180.220.120.230.741.83-0.06-0.000.26
Full-Time Employees771021011028573---
Price to Book Ratio9.821.161.401.402.894.043.573.014.19
Return on Assets-45.71-62.73-38.28-30.61-20.86-15.14-18.19-28.68-36.71
Return on Equity-85.05-110.45-56.39-39.36-25.32-19.62-30.48-49.56-66.48
Return on Invested Capital-92.85-85.19-55.59-42.37-22.47-11.61-30.75-42.82-31.75
Quick Ratio2.721.851.152.493.867.850.871.081.02
Current Ratio2.802.081.412.844.038.050.971.191.12

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-12.38-10.11-21.70-19.34-19.98-13.32-5.60-3.70-5.78
Depreciation0.681.163.674.255.033.002.842.551.72
Other Funds (Non Cash)1.901.5315.9712.293.192.213.151.291.63
Funds from Operations-9.93-7.54-4.88-4.11-12.45-8.370.32-0.20-2.88
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital1.01-1.490.281.76-2.460.46-0.78-0.840.44
Income Taxes Payable--------0.02
Cash from Operating Activities-8.92-9.03-4.60-2.36-14.92-7.91-0.46-1.04-2.43
Capital Expenditures-0.14-0.29-0.57-1.03-1.12-1.00-1.09-0.43-0.49
Net Assets From Acquisitions-0.23-0.230.000.000.00-2.94-0.79-0.75-1.18
Sale of Fixed Assets and Businesses10.4010.330.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.230.000.00-0.21-0.45-0.210.000.000.00
Other Sources0.000.000.000.090.090.000.000.000.00
Cash from Investing Activities10.269.82-0.57-1.16-1.48-4.15-1.88-1.18-1.67
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock1.030.658.781.750.543.0633.710.377.25
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock1.030.658.781.750.543.0633.710.377.25
Proceedsfrom Stock Options1.030.658.781.750.543.0633.710.377.25
Issuance or Reduction of Debt, Net0.000.003.040.000.000.000.130.25-0.14
Change in Long Term Debt0.000.000.000.000.000.000.130.25-0.14
Issuance of Long Term Debt0.000.000.000.000.000.001.680.450.15
Reduction of Long Term Debt0.000.000.000.000.000.00-1.55-0.19-0.29
Net Financing Active Other Cash Flow0.030.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.030.000.000.000.000.000.000.000.00
Cash from Financing Activities0.600.0810.690.76-0.472.3033.120.137.10
Exchange Rate Effect-0.38-0.37-0.31-0.810.560.36-0.90-0.04-0.16
Net Change in Cash1.560.495.20-3.57-16.31-9.4029.89-2.132.83
Free Cash Flow-9.06-9.32-5.17-3.39-16.04-8.76-1.55-1.39-2.92
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit--0.13-2.82-1.31-0.70-0.27-0.06-0.34-0.44

Balance sheet, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Cash & Short Term Investments5.438.3410.3911.783.547.72
Short Term Receivables2.292.632.222.991.883.48
Inventories0.440.360.360.380.381.52
Other Current Assets0.540.590.920.3620.420.86
Total Current Assets8.7111.9213.8915.5126.2313.58
Net Property, Plant & Equipment2.872.992.993.023.1611.77
Total Investments and Advances0.090.090.090.090.090.09
Intangible Assets0.000.000.000.000.006.73
Deferred Tax Assets0.680.70----
Other Assets0.000.000.000.000.000.00
Total Assets12.3515.7016.9818.6329.4732.17
Short Term Debt Incl. Current Port. of LT Debt0.340.340.320.300.301.34
Accounts Payable3.883.072.462.452.373.82
Income Tax Payable0.130.060.240.300.000.34
Other Current Liabilities0.380.790.690.659.411.02
Total Current Liabilities4.734.253.713.7012.076.52
Long Term Debt2.142.252.292.292.398.36
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.550.56---0.18
Other Liabilities0.000.000.000.000.000.00
Total Liabilities7.427.076.005.9914.4715.07
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity4.938.6310.9712.6415.0017.10
Total Shareholders Equity4.938.6310.9712.6415.0017.10
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity4.938.6310.9712.6415.0017.10
Total Liabilities & Stockholders Equity12.3515.7016.9818.6329.4732.17
Book Value Per Share0.100.180.230.270.330.37
Tangible Book Value Per Share0.100.180.230.270.330.22
Full-Time Employees-77---102
Price to Book Ratio9.825.075.925.754.481.16
Return on Assets-58.96-45.73-39.85-71.27-59.44-56.60
Return on Equity-123.73-85.07-68.13-121.78-110.96-102.71
Return on Invested Capital-61.67-25.90-21.36-15.43-12.38-5.97
Quick Ratio1.752.723.644.092.141.85
Current Ratio1.842.803.744.192.172.08

Cash flow, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Net Income-4.36-2.91-2.83-2.28-2.15-1.50
Depreciation0.190.190.160.140.690.64
Other Funds (Non Cash)0.430.580.520.370.070.35
Funds from Operations-3.74-2.28-2.16-1.76-1.40-0.51
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.840.430.01-0.28-1.67-0.29
Cash from Operating Activities-2.89-1.84-2.14-2.04-3.07-0.80
Capital Expenditures-0.06-0.01-0.02-0.05-0.21-0.25
Net Assets From Acquisitions0.00-0.230.000.000.000.00
Sale of Fixed Assets and Businesses0.0010.400.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.22-0.000.00-0.230.00
Other Sources0.00-10.2810.280.000.000.00
Cash from Investing Activities-0.060.1110.25-0.05-0.43-0.25
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.38-0.010.670.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.38-0.010.670.000.000.00
Proceedsfrom Stock Options0.38-0.010.670.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.00-0.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.00-10.1810.22-0.030.00
Other Financing Activities Uses0.000.000.09-0.06-0.030.00
Cash from Financing Activities0.25-0.20-9.5910.15-0.27-0.31
Exchange Rate Effect0.04-0.02-0.28-0.120.04-0.21
Net Change in Cash-2.67-1.96-1.767.94-3.73-1.56
Free Cash Flow-2.95-1.86-2.17-2.09-3.27-1.05

Revenue breakdown

Cryo Storage2024: 159.28K 2025: 110.15K
Product Sales2024: 5.02K 2025: 725
Project2024: 7.46M 2025: 11.16M
All Other Countries2024: 315.69K 2025: 785.54K
Australia2024: 642.85K 2025: 760.90K
Canada2024: 167.89K 2025: 233.34K
Europe2024: 281.97K 2025: 2.03M
United States2024: 6.22M 2025: 7.47M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.45%1.1M43.1M212.88K
2026-10-152.38%1.0M42.7M238.73K
2026-09-301.66%0.7M42.7M201.06K
2026-09-151.71%0.7M42.7M210.21K
2026-08-311.83%0.8M42.6M259.82K
2026-08-141.67%0.7M42.7M366.55K
2026-07-312.18%0.9M42.7M367.61K
2026-07-152.25%1.0M42.4M344.04K
2026-06-302.02%0.9M42.4M339.52K
2026-06-152.32%1.0M42.4M318.72K
2026-05-292.07%0.9M42.4M372.08K
2026-05-151.55%0.7M42.4M301.91K
2026-04-301.92%0.8M42.4M339.60K
2026-04-151.83%0.8M42.4M399.83K
2026-03-311.93%0.8M40.6M524.60K
2026-03-132.22%0.9M40.6M557.46K
2026-02-272.00%0.8M40.6M465.03K
2026-02-132.24%0.9M40.6M472.78K
2026-01-302.16%0.9M40.6M471.93K
2026-01-151.93%0.8M40.6M462.23K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.100.055.3941,9070.000.270-0.0160.001
call5.000.000.050.106.3275220.000.139-0.0130.000
call7.500.000.200.057.37439.000.000.129-0.0140.000
put2.501.101.851.5010.0736.000.00-0.730-0.0160.001
put5.003.504.500.0014.8120.000.00-0.861-0.0120.000
put7.506.007.005.9015.9780.000.00-0.872-0.0130.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-04SEC
2026-10-306-K/A2026-10-29SEC
2026-10-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-28SEC
2026-10-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-22SEC
2026-10-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-21SEC
2026-10-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-14SEC
2026-10-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-06SEC
2026-10-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-01SEC
2026-09-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-21SEC
2026-09-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-21SEC
2026-09-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-14SEC
2026-09-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-31SEC
2026-09-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-14SEC
2026-09-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-08SEC
2026-07-30EFFECTEffectiveness filing by commission orderSEC
2026-07-28F-3/ASEC
2026-07-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-23SEC
2026-07-2320-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2026-04-30SEC
2026-07-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-22SEC
2026-07-13F-3Registration statement for specified transactions by certain foreign private issuersSEC
2026-07-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-13SEC
2026-07-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-06SEC
2026-07-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-01SEC
2026-06-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-12SEC
2026-06-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-10SEC
2026-06-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-02SEC
2026-05-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-27SEC
2026-05-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-18SEC
2026-04-23SCHEDULE 13G/ASEC
2026-03-316-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
INGALLS & SNYDER LLC6.50%
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.11%
RENAISSANCE TECHNOLOGIES LLC0.46%
BlackRock, Inc.0.33%
MARSHALL WACE, LLP0.29%
BANK OF MONTREAL /CAN/0.20%
Allianz Asset Management GmbH0.07%
GSA CAPITAL PARTNERS LLP0.07%
Gradient Capital Advisors, LLC0.06%
GEODE CAPITAL MANAGEMENT, LLC0.05%

Funds

Fund% owned
iShares Micro-Cap ETF0.31%
1290 VT Micro Cap Portfolio0.02%
Fidelity Nasdaq Composite Index Fund0.02%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. HYFT. Cached 15 minutes.

Some panels did not load: insider.